VPRIV Infusion
Velaglucerase alfa
400 Unit
SHIRE PHARMACEUTICALS IRELAND LIMITED
| Pack size | 1 Glass Vial |
|---|---|
| Dispensing mode | POM |
| Source | IRELAND |
| Agent | CITY MEDICAL STORE |
| Retail Price | 6680.50 AED |
Indications
VPRIV Infusion is used for:
Velaglucerase alfa is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy for pediatric and adult patients with type 1 Gaucher disease.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Velaglucerase alfa :
Mechanism of Action
Velaglucerase alfa catalyzes the hydrolysis of glucocerebroside, reducing the amount of accumulated glucocerebroside.
Note
VPRIV 400 Unit Infusion manufactured by SHIRE PHARMACEUTICALS IRELAND LIMITED. Its generic name is Velaglucerase alfa. VPRIV is availble in United Arab Emirates.
Farmaco UAE drug index information on VPRIV Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.